Recent Finacing
Recent Raise
TetraLogic Pharmaceuticals is a Malvern, PA biotech developing birinapant (TL32711), a SMAC‑mimetic small molecule that antagonizes IAPs to trigger caspase‑mediated tumor cell death in Phase 1–2 oncology trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor